DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Hoffmann M, Kleine-Weber H, Schroeder S. et al.
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.
Cell 2020;
181: 271-280
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.